CytomX Therapeutics Inc (FRA:6C1)
€ 1.065 -0.022 (-2.02%) Market Cap: 76.88 Mil Enterprise Value: -26.16 Mil PE Ratio: 6.00 PB Ratio: 0 GF Score: 56/100

CytomX Therapeutics Inc (FRA:6C1) Transcripts

  • 1